Stocks · Healthcare · Biotechnology
Inhibrx Biosciences Inc. INBX
$94.56 -2.51% Close, Oct 5, 2026 · NASDAQ · Market cap $1.42B
Next earnings report: Nov 13, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +169.6%, ahead of the S&P 500 by 153.9 percentage points.
- The stock is in an uptrend: above its 200-day average for 42 trading days, with the 50-day average above the 200-day.
- The company holds net cash of $128.0M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 2%
- Revenue growth, 3-year CAGRBottom 9%
- Revenue growth accelerationBottom 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 10%
- Accruals (lower is better)Bottom 36%
- Interest coverBottom 35%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 47%
- Free-cash-flow yieldBottom 38%
- EBITDA / enterprise valueBottom 40%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 5%
- 6-month returnTop 22%
- 1-year return vs S&P 500Top 7%
- Distance from 52-week highBottom 41%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 40%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 25%
- Upside to consensus price targetTop 19%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 36%
- Maximum drawdown, 3 yearsBottom 47%
- Beta vs S&P 500 (lower is better)Bottom 38%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 550.0% | -100.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -100.0% | 550.0% | ↓ | Bottom 2% |
| Return on invested capital | -99.3% | — | Bottom 10% | |
| Revenue growth, 3-year CAGR | -16.0% | — | Bottom 9% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +13.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -8.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.23%
- Shareholder yield
- -0.23%
- Share count change, 1 year
- +1.3%
- Share count change, 3-year CAGR
- -28.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -1.1%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $285.00
- Target vs current price
- +201.4%
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 60%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -2.6% | -1.4% | +3.2% | +13.3% | — |
| May 14, 2026 | +9.3% | -1.5% | -6.7% | -20.7% | -21.1% |
| Mar 19, 2026 | -1.4% | -5.6% | -3.2% | +21.0% | +34.2% |
| Nov 14, 2025 | -9.6% | +6.0% | +7.0% | +6.6% | +9.9% |
| Aug 13, 2025 | +36.6% | +7.5% | +4.9% | +26.1% | +275.3% |
| May 14, 2025 | -9.8% | -3.9% | +15.9% | +30.1% | +86.7% |
| Mar 17, 2025 | -7.3% | -1.1% | +1.8% | -17.7% | +9.0% |
| Nov 14, 2024 | +7.2% | -7.2% | -9.1% | -4.5% | -17.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$2.34 | -$2.28 | -2.6% | — |
| May 14, 2026 | -$2.15 | -$2.37 | +9.3% | — |
| Mar 19, 2026 | -$2.11 | -$2.08 | -1.4% | — |
| Nov 14, 2025 | -$2.28 | -$2.08 | -9.6% | — |
| Aug 13, 2025 | -$1.85 | -$2.92 | +36.6% | $1.3M |
| May 14, 2025 | -$2.80 | -$2.55 | -9.8% | — |
| Mar 17, 2025 | -$3.09 | -$2.88 | -7.3% | $100,000 |
| Nov 14, 2024 | -$2.84 | -$3.06 | +7.2% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -9.27% | — | — | Bottom 38% |
| Earnings yield | -9.39% | — | — | Bottom 47% |
P/E over the past five years
Range 0.1× – 0.1× since Jun 30, 2024. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 42
- 50-day average slope (20 days)
- +5.2%
- 200-day average slope (20 days)
- +2.4%
- Distance from 50-day average
- -7.5%
- Distance from 200-day average
- +3.8%
- RSI (14)
- 37.4
- Relative volume
- 0.57×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 63.0%
- Volatility vs own 5-year history
- 36th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.33
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -33.3%
- Maximum drawdown, 3 years
- -72.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 17, 2020 | Jun 14, 2022 | -83.0% | 374 days | 843 days (Oct 24, 2025) |
| May 6, 2026 | Jul 29, 2026 | -44.1% | 57 days | Not yet recovered |
| Dec 8, 2025 | Mar 27, 2026 | -37.6% | 75 days | 17 days (Apr 22, 2026) |
| Oct 27, 2020 | Nov 2, 2020 | -27.0% | 4 days | 12 days (Nov 18, 2020) |
| Nov 5, 2025 | Nov 12, 2025 | -10.9% | 5 days | 7 days (Nov 21, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.42B
- EPS, diluted (TTM)
- -$8.88
- Revenue (TTM)
- $0
- 52-week range
- $28.16 – $155.29
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $7.1M | $2.2M | $1.8M | $200,000 | $1.3M |
| Gross profit | $4.4M | -$108.0M | $609,000 | -$2.1M | -$1.2M |
| Operating income | -$76.7M | -$129.1M | -$219.2M | -$331.4M | -$135.0M |
| Net income | -$81.8M | -$145.2M | -$241.4M | $1.69B | -$140.1M |
| EPS (diluted) | -$2.15 | -$3.62 | -$5.12 | $116.58 | -$9.04 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $100,000 | $0 | $1.3M | $0 | $0 | $0 | $0 |
| Net income | -$43.9M | -$47.9M | -$43.3M | -$28.7M | -$35.3M | -$32.8M | -$33.4M | -$36.6M |
| EPS (diluted) | -$2.84 | -$3.31 | -$2.80 | -$1.85 | -$2.28 | -$2.11 | -$2.15 | -$2.34 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$80.3M | -$115.3M | -$193.3M | -$194.4M | -$129.8M |
| Capital expenditure | -$864,000 | -$686,000 | -$4.6M | -$2.6M | -$31,000 |
| Free cash flow | -$81.2M | -$116.0M | -$197.9M | -$197.0M | -$129.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $43.8M | $129.7M | $202.0M | $71.7M | $1.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $133.3M
- Total assets
- $154.2M
- Total liabilities
- $207.2M
- Total debt
- $5.3M
- Net debt
- -$128.0M
- Shareholders’ equity
- -$53.0M
As of Jun 30, 2026 (filed Aug 13, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| May 30, 2024 | $0.85 | Jun 20, 2024 |
Short interest
- Shares sold short
- 3,393,511
- Days to cover
- 8.31
- Change vs previous report
- +2.9%
FINRA short interest, settlement date Sep 15, 2026.